New Clinical Trial Accepting Patients, Hopes to Ease Type 1 Diabetes Management

A first-of-its-kind advanced insulin delivery system could help type 1 diabetes patients manage their condition without continuously adjusting insulin doses on their own.

7:00 AM

Author | Kylie Urban

Three million.

That's the number of Americans who have type 1 diabetes, with 15,000 new cases diagnosed in both children and adults each year, according to the Juvenile Diabetes Research Foundation.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"Type 1 diabetes is a very serious and challenging disease for those affected," says Rodica Pop-Busui, M.D., Ph.D., professor of internal medicine in the Michigan Medicine Division of Metabolism, Endocrinology and Diabetes. "In spite of important discoveries in patient care and prevention of complications, living daily with type 1 diabetes continues to be a struggle for many patients."

We hope to help patients across all ages with type 1 diabetes reach better glucose control with lower risk for hypoglycemia and better quality of life.
Rodica Pop-Busui, M.D., Ph.D.

Type 1 diabetes requires patients to participate in their health management and care, with continuous insulin dose adjustments that can be a daily hardship for many patients with the condition.

To help, a new large, multicenter, nationwide clinical trial aims to make managing the condition easier for patients.

The trial, funded by Medtronic, will be the largest one to date using the world's first hybrid closed-loop system automated insulin delivery device.

"The system monitors blood glucose levels and insulin delivery continuously and adjusts automatically the dose of insulin, helps the patient maintain stable blood sugar levels throughout the day and night and enables personalized and automated delivery of basal insulin," says Pop-Busui, the primary investigator of Michigan Medicine's trial site.

"Thus by acting like an artificial pancreas, it is bypassing many of the patients' frequent insulin dose calculations and alleviating some of the burden associated with daily diabetes management, which can be strenuous and wearing."

The MiniMed 670G Insulin Pump System from Medtronic. ( Source: Medtronic)

Details on the clinical trial

The trial at Michigan Medicine is a team-based, collaborative effort between the adult and pediatric endocrinology clinics.

SEE ALSO: Sugar Shock: Insulin Costs Tripled in 10 Years

Patients ages 2 to 80 will be enrolled in the trial and will have their type 1 diabetes monitored at home for 12 months using Medtronic's MiniMed 670G system. The device will monitor blood glucose and glycemic control. Patients will need to enter carbohydrates they consume at mealtimes, accept bolus correction recommendations and periodically calibrate the sensor.

Up to 1,500 patients can enroll in the new study, regardless of their previous diabetes management and treatment plans. The investigators hope to use data collected in the trial to demonstrate the long-term safety and effectiveness of the hybrid closed-loop system in daily type 1 diabetes management.

"We hope to help patients across all ages with type 1 diabetes reach better glucose control with lower risk for hypoglycemia and better quality of life," Pop-Busui says. "We are working together, adult and pediatric endocrinologist physicians and nurse investigators, in a concerted effort to fight diabetes and its complications."

The trial is currently enrolling. To find more information and see if you may be a candidate, visit

More Articles About: Body Work Diabetes Type 1 Diabetes Metabolism, Endocrinology & Diabetes
Health Lab word mark overlaying blue cells
Health Lab

This article is from the Health Lab digital publication.

Media Contact Public Relations

Department of Communication at Michigan Medicine



Get a weekly digest of medical research and innovation, straight to your inbox.

Featured News & Stories Watercolor Painting People Rain Umbrella
Health Lab
Support from others in stressful times can ease impact of genetic depression risk
Stress can interact with genetic vulnerability to depression, and with added or lacking support from friends and family, to affect depressive symptoms.
lab bench scientist white coat in lab doing experiment
Health Lab
Research with a purpose
Alyssa Dreffs, originally a patient, is now a researcher with personal motivation behind her work.
scientists together at computer in white coats
Health Lab
Researchers uncover new cell types involved in osteoarthritis
And the development of a new slow-release drug seeks to target them
Food blood vial collage
Health Lab
Blood-based metabolic signature outperforms standard method for predicting diet, disease risk
The study found that machine learning techniques improved diet prediction by 10-20%.
senior woman blowing nose blanket
Health Lab
Study hints at why older people are more susceptible to the flu
Influenza is back in circulation, posing a special danger to older adults.
muscle weakness guy sitting clock on wall pink red and grey smoke and time clocks tired weight on floor
Health Lab
Is muscle weakness the new smoking?
Researchers say the study finding is some of the first evidence linking muscle weakness and biological age acceleration